Delivery Order SPE2DB22D3501-SPE2DB25FWM73
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,774.15 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120 count) on July 21, 2025, with completion scheduled for July 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count packages) with a ceiling value of $184,749.89. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count) valued at $13,701.92. This firm fixed-price delivery order is classified as non-competitive and will be completed by July 22, 2025. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a ceiling value of $25,102.49. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 28, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a pediatric delivery against AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count units) with a ceiling value of $41.4K. This competitive, non-set-aside contract utilizes firm fixed pricing and maintains an ultimate completion date of July 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- This is a $9,372.25 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency for the supply of Abiraterone Acetate 250 mg tablets. The contract has an ultimate completion date of July 2, 2025 and is not set aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, providing a comprehensive global...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,253,531 units of Abiraterone Acetate 250 mg tablets. The $1,530.13 delivery order has a completion date of January 8, 2024. AmerisourceBergen Drug Corp, operating out of its corporate office in Conshohocken, Pennsylvania, has an existing indefinite delivery contract with the Department of Justice Federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,313.32, is for the supply of 4,566,561,596 units of abiraterone acetate 250 mg tablets. The contract is a firm fixed-price delivery order with a completion date of November 29, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,822.78 firm fixed price delivery order is for the supply of 4565133468 Abiraterone Acetate 250 mg tablets. The contract has a ceiling value of $1,822.78 and a completion date of July 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,420.28, is for the delivery of abiraterone acetate 250 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWM73Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $96,898.94 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen supplies brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support military and veteran healthcare needs. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency's Medical Supply Chain, demonstrating its capability to meet competitive procurement requirements across a wide range of pharmaceutical products. This delivery order for Abiroterone Acetate—a hormone therapy medication used in cancer treatment—exemplifies the company's role as a critical vendor for specialized pharmaceutical commodities supporting defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $96.9k | 7/21/25 |